Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast To 2017 - MarketsandMarkets

Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast To 2017

Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast To 2017 - MarketsandMarkets
Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast To 2017
Published Jan 10, 2013
286 pages — Published Jan 10, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

Contrast media have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Sophisticated techniques such as targeted MRI imaging and gas microbubble technology in ultrasound will prove to be essential drivers in the widespread use of contrast agents in the future.

The global market is broadly segmented into barium-based, iodinated and gadolinium-based contrast media. These products are further categorized based on the medical procedure (X-ray, CT, MRI, ultrasound, and catheterization laboratory), route of administration (oral, injection, rectal, and urethral), medical indication (cardiovascular, respiratory, musculoskeletal, gastrointestinal, and neurology, nephrology and oncology) and finally application (radiology, interventional radiology and interventional cardiology). The global market is worth $6.2 billion in 2012, and estimated to grow at a CAGR of 6.8% to reach $8.6 billion by 2017.

The global contrast agent market, though fairly mature at present (2012), still shows potential to grow over the next five years. It is propelled by the increasing demand for diagnostic imaging and image guided surgical procedures, technological advances in diagnostic imaging and the ever-increasing incidence rates of cancer and cardiac disorders. However, a few pivotal factors affecting the growth of this market are major economies of the world undergoing healthcare reforms, thereby affecting contrast media sales and the economic slowdown restricting the overall growth of this market.

The U.S. represents the largest contrast agent market worldwide, followed by Europe and Japan. However, the economic slowdown has augmented opportunities for emerging markets like India and China to strengthen their position in the global arena. Advances in medical technology coupled with huge foreign investments from developed nations, allows these emerging markets to compete with global market leaders in this segment. Investment firms are increasingly focusing on expansion in developing markets of Asia, Latin America and Eastern Europe, since the U.S. is on the brink of embracing healthcare reforms and major economies in Europe are still recovering from huge financial deficits.

The global market place is highly competitive, with several small players specific to a particular geography challenging major ones. Owing to the recession and the emerging opportunities in developing countries, many small companies have similar product offerings at competitive prices. Some of the major players profiled in this report are GE Healthcare (U.K.), Bracco Diagnostic, Inc. (Italy), Bayer Healthcare Pharmaceuticals (Germany), Covidien (Ireland) and Guerbet Group (France).

The scope of the report spans the global contrast media market which comprises:

By Product

Barium-based contrast media
Iodinated contrast media
Low-osmolar contrast media (LOCM)
High-osmolar contrast media (HOCM)
Gadolinium-based contrast media

By Route of Administration

Oral
Injection
Intravenous (I.V.)
Intra-arterial (I.A.)
Rectal
Urethral

By Medical Procedure

X-ray
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Ultrasound
Catheterization laboratory (cath lab)

By Indication

Cardiovascular disorders
Neurological disorders
Gastrointestinal disorders
Respiratory diseases
Musculoskeletal anomalies<

  
Source:
Document ID
MD 1371
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 INCREASING DEMAND FOR DIAGNOSTIC & IMAGE GUIDED PROCEDURES INFLUENCES CONTRAST MEDIA SALES
3.3.1.2 TECHNOLOGICAL ADVANCEMENTS TO SPUR THE CONTRAST MEDIA MARKET
3.3.1.3 INCREASING INCIDENCE & MORTALITY OF CANCER & CARDIAC DISEASES TO BOOST GROWTH OF CONTRAST MEDIA
3.3.1.4 GROWTH OF MEDICAL IMAGING TECHNOLOGY IN EMERGING MARKETS
3.3.2 RESTRAINTS
3.3.2.1 MAJOR ECONOMIES UNDERGOING HEALTHCARE REFORMS TO AFFECT THE SALES ON CONTRAST MEDIA
3.3.2.2 ECONOMIC SLOWDOWN TO INHIBIT GROWTH
3.3.3 OPPORTUNITIES
3.3.3.1 GROWING INVESTMENT POTENTIAL IN IMMATURE EMERGING MARKETS
3.3.3.2 ADVENT OF NOVEL CONTRAST AGENTS COMBINING PROPERTIES OF CONTRAST MEDIA & RADIOPHARMACEUTICALS
3.3.4 BURNING ISSUE - TOXICITY
3.3.4.1 NEPHROGENIC SYSTEMIC FIBROSIS (NSF)
3.3.4.2 CONTRAST-INDUCED NEPHROTOXICITY (CIN)
3.3.5 TECHNOLOGY TRENDS
3.3.5.1 N1177 - A REVOLUTIONARY MACROPHAGE LABELING AGENT
3.3.5.2 SPAGO PIX - ACCURATE VISUALIZATION OF TUMORS WITH MRI
3.3.5.3 CMC-001 - FOCUSED ON LIVER MRI
3.4 MARKET SHARE ANALYSIS

4 BY PRODUCT
4.1 INTRODUCTION
4.2 BARIUM-BASED CONTRAST MEDIA
4.2.1 TECHNICAL OVERVIEW
4.2.2 MARKET DYNAMICS
4.2.3 MARKET ANALYSIS
4.3 IODINATED CONTRAST MEDIA
4.3.1 TECHNICAL OVERVIEW
4.3.2 MARKET DYNAMICS
4.3.3 MARKET ANALYSIS
4.3.4 TYPES - LOW-OSMOLAR AND HIGH-OSMOLAR
4.3.4.1 LOW-OSMOLAR CONTRAST MEDIA (LOCM)
4.3.4.1.1 TECHNICAL OVERVIEW
4.3.4.1.2 MARKET ANALYSIS
4.3.4.2 HIGH-OSMOLAR CONTRAST MEDIA (HOCM)
4.3.4.2.1 TECHNICAL OVERVIEW
4.3.4.2.2 MARKET ANALYSIS
4.4 GADOLINIUM-BASED CONTRAST MEDIA
4.4.1 TECHNICAL OVERVIEW
4.4.2 MARKET DYNAMICS
4.4.3 MARKET ANALYSIS

5 BY ROUTE OF ADMINISTRATION
5.1 INTRODUCTION
5.2 ORAL CONTRAST MEDIA
5.2.1 TECHNICAL OVERVIEW
5.2.2 MARKET DYNAMICS
5.2.3 MARKET ANALYSIS
5.3 INJECTABLE CONTRAST MEDIA
5.3.1 TECHNICAL OVERVIEW
5.3.2 MARKET DYNAMICS
5.3.3 MARKET ANALYSIS
5.3.4 INJECTABLE CONTRAST MEDIA - TYPES
5.3.4.1 INTRAVENOUS (IV)
5.3.4.2 INTRA-ARTERIAL (IA)
5.4 RECTAL CONTRAST MEDIA
5.4.1 TECHNICAL OVERVIEW
5.4.2 MARKET DYNAMICS
5.4.3 MARKET ANALYSIS
5.5 URETHRAL CONTRAST MEDIA
5.5.1 TECHNICAL OVERVIEW
5.5.2 MARKET DYNAMICS
5.5.3 MARKET ANALYSIS

6 BY MEDICAL PROCEDURE
6.1 INTRODUCTION
6.2 X-RAY
6.2.1 TECHNICAL OVERVIEW
6.2.2 MARKET DYNAMICS
6.2.3 MARKET ANALYSIS
6.3 COMPUTED TOMOGRAPHY (CT)
6.3.1 TECHNICAL OVERVIEW
6.3.2 MARKET DYNAMICS
6.3.3 MARKET ANALYSIS
6.4 MAGNETIC RESONANCE IMAGING (MRI)
6.4.1 TECHNICAL OVERVIEW
6.4.2 MARKET DYNAMICS
6.4.3 MARKET

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast To 2017" Jan 10, 2013. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Contrast-Media-Contrast-Agents-Market-By-Product-Iodinated-Gadolinium-Barium-By-Technique-X-Ray-CT-MRI-Cath-Lab-Ultrasound-By-Application-Radiology-Interventional-Radiology-Interventional-Cardiology-Global-Trends-Forecast-To-2017-2144-23>
  
APA:
MarketsandMarkets. (2013). Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-Ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast To 2017 Jan 10, 2013. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Contrast-Media-Contrast-Agents-Market-By-Product-Iodinated-Gadolinium-Barium-By-Technique-X-Ray-CT-MRI-Cath-Lab-Ultrasound-By-Application-Radiology-Interventional-Radiology-Interventional-Cardiology-Global-Trends-Forecast-To-2017-2144-23>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.